Determinants of cancer care delays in Kinshasa, Democratic Republic of the Congo (DRC)

Background Cancer outcomes in sub-Saharan Africa are driven by delayed diagnosis and treatment initiation. We evaluated the magnitude and determinants of diagnostic and treatment delays among cancer patients in Kinshasa, Democratic Republic of the Congo (DRC). Methods We conducted a hospital-based cross-sectional study of 460 adults with confirmed cancer at Nganda Hospital Center in Kinshasa, DRC. Two outcomes were assessed: delay from symptom onset to diagnosis and delay from diagnosis to treatment initiation. Log-normal regression models were fitted for each outcome to estimate adjusted geometric mean ratios (aGMRs) and 95% confidence intervals (CIs). Covariates included demographic, socioeconomic, clinical, behavioral, and stigma-related factors. Results The median age was 55 years, and 76.2% of participants were women. Overall, 55.0% of participants experienced symptom-to-diagnosis delays > 6 months, and 49.4% experienced diagnosis-to-treatment delays > 3 months. Age ≥ 65 years was associated with longer diagnostic delay (aGMR 1.55, 95% CI 1.03–2.31) and age 50–64 years with longer treatment delay (1.51, 1.07–2.14). No work outside the household in the past 7 days was associated with both diagnostic delay (1.68, 1.15–2.47) and treatment delay (2.27, 1.54–3.33). Longer diagnostic delay was additionally associated with informal trading (1.99, 1.21–3.28) and shared taxi or motorbike transport (1.92, 1.25–2.94), while high cancer-stereotype stigma was associated with longer treatment delay (1.56, 1.04–2.34). Associations with hepatitis B infection (diagnostic delay 1.88, 1.06–3.34; treatment delay 2.42, 1.15–5.11) and smoking (diagnostic delay 2.25, 1.03–4.91) were based on small numbers ( n = 14 each) and were imprecisely estimated. Conclusions Substantial delays exist across the DRC cancer care continuum and are associated with markers of socioeconomic vulnerability, transport barriers and cancer-related stigma. These findings highlight the need for integrated interventions to improve timely diagnosis and treatment initiation, including strengthening financial protection, decentralizing cancer services, and reducing stigma in cancer care.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-11-21
DOI
https://doi.org/10.1186/s12885-026-17405-0
Citations
1
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
2.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Determinants of cancer care delays in Kinshasa, Democratic Republic of the Congo (DRC)

Pélagie Babakazo, Fidéle Lumande Kasindi, Kavita Sehrawat, Ali Alisho et al.
1 citations
BMC Cancer
Global Cancer Incidence and Screening
2.05
article

Determinants of cancer care delays in Kinshasa, Democratic Republic of the Congo (DRC)

Pélagie Babakazo, Fidéle Lumande Kasindi, Kavita Sehrawat, Ali Alisho, Jean Claude Dusingize, Marcel Yotebieng, Natalia Zotova, Ilyass Yessoufou, Rafi Kabarriti, Assan Isangu, on behalf of CA-IeDEA, Arnold Sulu
article en
1 citations

Abstract

Background Cancer outcomes in sub-Saharan Africa are driven by delayed diagnosis and treatment initiation. We evaluated the magnitude and determinants of diagnostic and treatment delays among cancer patients in Kinshasa, Democratic Republic of the Congo (DRC). Methods We conducted a hospital-based cross-sectional study of 460 adults with confirmed cancer at Nganda Hospital Center in Kinshasa, DRC. Two outcomes were assessed: delay from symptom onset to diagnosis and delay from diagnosis to treatment initiation. Log-normal regression models were fitted for each outcome to estimate adjusted geometric mean ratios (aGMRs) and 95% confidence intervals (CIs). Covariates included demographic, socioeconomic, clinical, behavioral, and stigma-related factors. Results The median age was 55 years, and 76.2% of participants were women. Overall, 55.0% of participants experienced symptom-to-diagnosis delays > 6 months, and 49.4% experienced diagnosis-to-treatment delays > 3 months. Age ≥ 65 years was associated with longer diagnostic delay (aGMR 1.55, 95% CI 1.03–2.31) and age 50–64 years with longer treatment delay (1.51, 1.07–2.14). No work outside the household in the past 7 days was associated with both diagnostic delay (1.68, 1.15–2.47) and treatment delay (2.27, 1.54–3.33). Longer diagnostic delay was additionally associated with informal trading (1.99, 1.21–3.28) and shared taxi or motorbike transport (1.92, 1.25–2.94), while high cancer-stereotype stigma was associated with longer treatment delay (1.56, 1.04–2.34). Associations with hepatitis B infection (diagnostic delay 1.88, 1.06–3.34; treatment delay 2.42, 1.15–5.11) and smoking (diagnostic delay 2.25, 1.03–4.91) were based on small numbers ( n = 14 each) and were imprecisely estimated. Conclusions Substantial delays exist across the DRC cancer care continuum and are associated with markers of socioeconomic vulnerability, transport barriers and cancer-related stigma. These findings highlight the need for integrated interventions to improve timely diagnosis and treatment initiation, including strengthening financial protection, decentralizing cancer services, and reducing stigma in cancer care.

BMC Cancer
Albert Einstein College of Medicine (US), University of Kinshasa (CD), Ecole de santé publique de Kinshasa (CD)
National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Cancer Institute, National Institute of Allergy and Infectious Diseases, Fogarty International Center, National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Library of Medicine
Good health and well-being, Reduced inequalities
Openalex Percentile: Top 19%
Global Cancer Incidence and Screening
2.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon